You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase 1/Phase 1b

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Sarcoidosis Trial (XTMAB-16 or Placebo)

Not yet recruiting
  • Pulmonary Sarcoidosis
  • XTMAB-16 or Placebo
  • (no location specified)
May 25, 2023

Cancer Trial (Antibody-Drug Conjugate)

Not yet recruiting
  • Cancer
  • Antibody-Drug Conjugate
  • (no location specified)
Aug 23, 2023

Alcohol Use Disorder Trial in Glendale (DCR-AUD, Placebo)

Active, not recruiting
  • Alcohol Use Disorder
  • Glendale, California
    Parexel Los Angeles Early Phase Clinical Unit
Apr 26, 2023

Acute Myeloid Leukemia Trial in Houston (ASTX727, ASTX029-01)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    MD Anderson Cancer Center
Oct 27, 2023

Cystic Fibrosis Trial in Christchurch (ABCI, Placebo)

Recruiting
  • Cystic Fibrosis
  • ABCI
  • Placebo
  • Christchurch, New Zealand
    New Zealand Clinical Research
Apr 4, 2023

Relapsed/Refractory Large B-cell Lymphoma Trial (KITE-197, Cyclophosphamide, Fludarabine)

Not yet recruiting
  • Relapsed/Refractory Large B-cell Lymphoma
  • (no location specified)
Oct 6, 2023

Chronic Inducible Urticaria Trial in Canada, United States (Oral EP262)

Recruiting
  • Chronic Inducible Urticaria
  • Oral EP262
  • Tampa, Florida
  • +5 more
Sep 18, 2023

Decompensated Cirrhosis Trial in Beijing (Human Umbilical Cord-derived Mesenchymal Stem Cells)

Not yet recruiting
  • Decompensated Cirrhosis
  • Human Umbilical Cord-derived Mesenchymal Stem Cells
  • Beijing, China
    Beijing 302 Hospital
Aug 2, 2023

Brain Tumor Trial in Houston (tepotinib, tepotinib plus osimertinib)

Not yet recruiting
  • Brain Tumor
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Leprosy Trial in Rio de Janeiro (LEP-F1 + GLA-SE, Placebo)

Not yet recruiting
  • Leprosy
  • LEP-F1 + GLA-SE
  • Placebo
  • Rio de Janeiro, Brazil
    Veronica Schmitz Pereira
Dec 5, 2022

Ulcerative Colitis Trial in Whittier (APL-1401, Placebo)

Not yet recruiting
  • Ulcerative Colitis
  • Whittier, California
    New Hope Research Development
Feb 15, 2023

Squamous Cell Carcinoma, RP1 Trial (RP1)

Not yet recruiting
  • Squamous Cell Carcinoma
  • RP1
  • (no location specified)
May 4, 2023

Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial (BGB-21447)

Not yet recruiting
  • Relapsed Non-Hodgkin Lymphoma
  • +6 more
  • (no location specified)
Apr 12, 2023

Advanced Malignancies Trial in Beijing (1A46 Drug Substance)

Not yet recruiting
  • Advanced Malignancies
  • 1A46 Drug Substance
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Aug 4, 2023

Healthy Trial in Pretoria (H107e, CAF®10b, H107e/CAF®10b - low adjuvant dose)

Not yet recruiting
  • Healthy
  • H107e
  • +10 more
  • Pretoria, Gauteng, South Africa
    Aurum Institute
Sep 24, 2023

RAS Mutation, NRAS Gene Mutation, Melanoma Trial in Phoenix, Newnan, Zion (OKI-179 + binimetinib)

Recruiting
  • RAS Mutation
  • +2 more
  • OKI-179 + binimetinib
  • Phoenix, Arizona
  • +4 more
Sep 22, 2022

Subcutaneous Fat Trial in Omaha (CBL-514 injection, CBL-A1 Injection, CBL-A2 Injection)

Not yet recruiting
  • Subcutaneous Fat
  • CBL-514 injection
  • +3 more
  • Omaha, Nebraska
    Investigational Site 1
Aug 17, 2023

Solid Tumor Trial in Houston (IMGS-001)

Recruiting
  • Solid Tumor
  • Houston, Texas
    MD Anderson Cancer Center
Aug 23, 2023

HIV-1-infection Trial (B/F/TAF)

Not yet recruiting
  • HIV-1-infection
  • (no location specified)
Oct 23, 2023

Colorectal Cancer Metastatic, Squamous Cell Carcinoma of Head and Neck Trial (WU-NK-101 - Dose Escalation, Cetuximab - Dose

Not yet recruiting
  • Colorectal Cancer Metastatic
  • Squamous Cell Carcinoma of Head and Neck
  • WU-NK-101 - Dose Escalation
  • +3 more
  • (no location specified)
Dec 30, 2022

Healthy Trial in Centennial (OPT101)

Active, not recruiting
  • Healthy
  • Centennial, Colorado
    IMMUNOe Research
Sep 22, 2022

Advanced Solid Tumors, HER2-positive Breast Cancer Trial in United States (ZN-A-1041 50mg BID, ZN-A-1041 100mg BID, ZN-A-1041

Recruiting
  • Advanced Solid Tumors
  • HER2-positive Breast Cancer
  • ZN-A-1041 50mg BID
  • +12 more
  • Tucson, Arizona
  • +6 more
Nov 16, 2022

Metastatic Breast Cancer Trial in Pompano Beach, Caracas (ConvitVax)

Not yet recruiting
  • Metastatic Breast Cancer
  • ConvitVax
  • Pompano Beach, Florida
  • +2 more
Aug 28, 2023

Vanishing White Matter Disease Trial in Salt Lake City (ABBV-CLS-7262)

Recruiting
  • Vanishing White Matter Disease
  • Salt Lake City, Utah
    University of Utah Hospital
Mar 6, 2023

Nasopharyngeal Carcinoma Trial in Guangzhou (BL-B01D1, capecitabine, gemcitabine)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 31, 2023